Concepedia

Matthew M. Burke

MM

Statistics

Publications

12

Citations

4.7K

H-Index

12

Active since

1985

Affiliations

Bristol-Myers Squibb (United States)(Current)

Yale Cancer Center

Yale University

Memorial Sloan Kettering Cancer Center

Smilow Cancer Hospital

Matthew M. Burke is an author at Bristol-Myers Squibb (United States) specializing in oncology, medicine, and immunotherapy.

Publications per year

1985–2020

12

Publications

12

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Harriet M. Kluger, Margaret K. Callahan et al. · New England Journal of Medicine · 2013 · 4.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL).

Mario Sznol, Harriet M. Kluger, Margaret K. Callahan et al. · Journal of Clinical Oncology · 2014 · 137 citations

Pharmacy, Oncology, Pharmacotherapy +17

Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL).

Mario Sznol, Harriet M. Kluger, Margaret K. Callahan et al. · Journal of Clinical Oncology · 2014 · 79 citations

Pharmacy, Oncology, Pharmacotherapy +17

The experiences of unpartnered men with prostate cancer: a qualitative analysis

Meredith Wallace Kazer, Janet Harden, Matthew M. Burke et al. · Journal of Cancer Survivorship · 2010 · 42 citations

Medicine, Oncology, Urology +11

Case Report: Response to Ipilimumab in a Patient With HIV With Metastatic Melanoma

Matthew M. Burke, Harriet M. Kluger, Marjorie Golden et al. · Journal of Clinical Oncology · 2011 · 38 citations

Medicine, Immunology, Oncology +11

1–5 of 12